James Loerop - EVP Business Development at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Business Development
Stock Symbol
ANIK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Loerop since 9/18/2023

Holdings reported by James Loerop for Anika Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.59K $104K $18.63 Jul 8, 2021 Direct
Restricted Stock Unit 3K $77.4K $25.79 Jul 8, 2021 Direct Common Stock

Transactions reported by James Loerop for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.